BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27246)

  • 21. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 22. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A
    J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Properties of 3':5'-AMP- and 3':5'-GMP-phosphodiesterases in the retina].
    Usova AA
    Ukr Biokhim Zh (1978); 1979; 51(1):35-40. PubMed ID: 218330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methylation of 3',5'-cGMP phosphodiesterase in retinal photoreceptor membranes].
    Artem'ev NO; Etingof RN
    Biokhimiia; 1987 Jan; 52(1):154-9. PubMed ID: 3028508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
    Grewal J; Karuppiah N; Mutus B
    Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
    Kurskiĭ MD; Osipenko AA; Prishchepa LA
    Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
    Weiss RM; Wheeler MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):630-4. PubMed ID: 2846825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
    Gillespie PG; Beavo JA
    Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
    Jackson BA; Edwards RM; Dousa TP
    Kidney Int; 1980 Oct; 18(4):512-8. PubMed ID: 6164816
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
    Manganiello V
    Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic nucleotide phosphodiesterase in rat parotid gland.
    Yokoyama N; Abe M; Furuyama S
    Can J Physiol Pharmacol; 1981 Mar; 59(3):293-9. PubMed ID: 6261905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
    Teng CT; Buchler B; Teng CS
    Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
    [No Abstract]   [Full Text] [Related]  

  • 38. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
    Liu YP; Schwartz HS
    Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic nucleotide phosphodiesterase assay technology.
    MacKenzie SJ; Hastings SF; Wells C
    Curr Protoc Pharmacol; 2010 Jun; Chapter 3():Unit 3.12. PubMed ID: 22294369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.